What is the inheritance pattern of Beckwith-Wiedemann syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Inheritance Pattern of Beckwith-Wiedemann Syndrome

At least 85% of Beckwith-Wiedemann syndrome cases are not inherited and occur sporadically due to epigenetic changes on chromosome 11p15, while the remaining familial cases demonstrate heterogeneous inheritance patterns that can include autosomal dominant with variable expressivity and reduced penetrance, though the exact pattern varies by molecular mechanism 1.

Sporadic Cases (85% of BWS)

The vast majority of BWS cases arise de novo and are not inherited from parents. These sporadic cases result from:

  • Loss of methylation at IC2 (50% of all BWS cases)
  • Paternal uniparental isodisomy (pUPD11) for chromosome 11p15 (20% of cases)
  • Gain of methylation at IC1 (5% of cases)
  • Chromosomal rearrangements involving 11p15 (<5% of cases)

These epigenetic and chromosomal changes typically occur randomly during early development and are mosaic in nature, meaning they affect only some cells in the body 1.

Familial Cases (15% of BWS)

When BWS is inherited, the pattern is complex and heterogeneous:

Autosomal Dominant Pattern

  • CDKN1C mutations (5% of all BWS cases) can be inherited in an autosomal dominant manner with variable expressivity and reduced penetrance
  • These mutations occur on the maternally derived copy of CDKN1C
  • Paternally inherited duplications of the 11p15 region can also cause hereditary BWS 1

Parent-of-Origin Effects (Genomic Imprinting)

A critical feature is that phenotypic manifestations depend on which parent transmits the genetic defect:

  • The syndrome typically manifests when the defective gene is inherited from the mother
  • This reflects the imprinted nature of genes in the 11p15 region, where certain genes are expressed only from the maternal or paternal chromosome 2

Mixed Inheritance Patterns

Research demonstrates that familial BWS does not follow a single inheritance pattern. Segregation analysis of 291 families revealed that familial cases may include:

  • Recessive inheritance patterns
  • Additive inheritance patterns
  • Sex-dependent inheritance patterns
  • Autosomal dominant patterns

This suggests familial BWS is a heterogeneous group comprised of different inheritance patterns depending on the underlying molecular mechanism 3.

Clinical Implications for Genetic Counseling

Any determination of recurrence risk for parents or testing of relatives should be performed by a genetics healthcare professional 1. The recurrence risk varies dramatically based on:

  • Sporadic epigenetic cases: Very low recurrence risk (<1%)
  • CDKN1C mutations: Up to 50% recurrence risk if inherited from mother
  • Chromosomal rearrangements: Variable risk depending on whether parent carries balanced translocation

Key Pitfalls to Avoid

  • Do not assume familial inheritance without molecular testing—most cases are sporadic
  • Tissue mosaicism can complicate genetic testing; a negative test does not exclude BWS 4, 5
  • Parent-of-origin matters: The same genetic change may have different effects depending on whether it's inherited maternally or paternally
  • Multiple tissue testing may be needed if initial testing is negative but clinical suspicion remains high 4

References

Related Questions

What is the recommended comprehensive management for a child with Beckwith‑Wiedemann syndrome, including tumor surveillance, hypoglycemia treatment, cardiac evaluation, and surgical considerations?
What is the recommended management plan for infants with Beckwith‑Wiedemann syndrome, including surveillance, hypoglycemia treatment, tumor screening, cardiac evaluation, surgical interventions, and genetic counseling?
With a suppressed TSH (0.1 µU/mL) and a T3 at the upper limit of normal (9.8 pmol/L), what is the appropriate treatment plan?
What oral contraceptive options are available in the United States for a healthy reproductive‑age woman without estrogen contraindications?
What are the symptoms of de Quervain's tenosynovitis?
How should joint and tendon stiffness caused by Teva immunotherapy, which interferes with fine‑motor tasks, be managed?
What topical cream should be used to treat a penile rash that may represent lichen sclerosus, psoriasis, or a fungal infection?
What is the recommended dicloxacillin dosage and duration for treating uncomplicated lymphangitis in an adult patient without a penicillin allergy, and when should alternative agents be used?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.